Author Archive

What Reduced Opioid Prescribing Means for Patients and Policy

New polling data from The Boston Globe reveals that U.S. physicians are prescribing fewer opioids. But how does the trend impact patients – and the

Read More

2016 in Review: Top Trends for Patient Access

  Hepatitis C patients keep waiting…and waiting…and waiting. Decreasing prices for treatment, the threat of legal action and input from the Centers for Medicare and

Read More

Hepatitis C and Opioid Abuse Epidemics Combine to Pose New Crisis

Two American public health epidemics are colliding – creating new headaches for policymakers and more heartache for communities across the country. As the opioid abuse

Read More

New Biosimilar Switching Paper Prioritizes Physician-Patient Relationship and Robust Pharmacovigilance

By Brian Kennedy, Executive Director, Global Alliance for Patient Access A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates

Read More

Webinar Offers Primer on Biosimilars Policy

If policymakers get it right, biosimilars could offer more safe and effective treatment options for patients in the coming years – potentially at lower costs.

Read More

Summit on Balanced Pain Management Tackles Access and Education Issues

There’s no way to address America’s prescription drug abuse crisis without balanced pain management, explained the National Institutes of Health’s Linda Porter, PhD, at Tuesday’s

Read More

Tennessee Poll Shows Impact of Non-Medical Switching

Polling results from Tennessee cast new light on a trend that’s sparking national concerns: non-medical switching. As the Tennessee Patient Stability Coalition reports, more than

Read More

“Accessing Cholesterol Treatments” is No Simple Task, Explains New Video

On the heels of recent research confirming breakthrough drugs’ impact on patients with high cholesterol, the Partnership to Advance Cardiovascular Health has released a quick-draw

Read More

The Wait Continues for Medicaid Patients with Hepatitis C

Despite being cautioned last year by the Centers for Medicare and Medicaid Services, many states still block patients with hepatitis C from receiving curative treatment.

Read More

Will New Evidence on PCSK9 Inhibitors Improve Patient Access?

For patients with extremely high cholesterol, the promise of new PCSK9 inhibitors just keeps growing. Data presented at this month’s American Heart Association meeting confirms

Read More
Back to Top